Chee Conley 4
4 · Syros Pharmaceuticals, Inc. · Filed Oct 11, 2022
Insider Transaction Report
Form 4
Chee Conley
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2022-10-06+34,000→ 34,000 total→ Common Stock (34,000 underlying) - Award
Stock Option (right to buy)
2022-10-06+44,500→ 44,500 totalExercise: $6.73Exp: 2032-10-05→ Common Stock (44,500 underlying)
Footnotes (3)
- [F1]This option becomes exercisable as to one half (50%) of the shares on October 31, 2023, and as to one half (50%) of the shares on October 31, 2024.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F3]These RSUs will vest as to one half (50%) of the shares on October 31, 2023, and as to one half (50%) of the shares on October 31, 2024.